跳至主要内容
临床试验/CTRI/2024/03/064297
CTRI/2024/03/064297尚未招募不适用

A randomized parallel arm comparative clinical study to evaluate the efficacy of pathyadi churna and avipattikar churna in the management of amlapitta.

Dr Samarth Kasliwal1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年3月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
110
试验地点
1
主要终点
To determine the effect of pathyadi churna in the

研究概览

简要总结

Amlapitta is a most remarkable Problem in the society in modern era. The use of an antacid has symptomatic relief only ,but is not reliable for long term medication.Madhavkara stated that, Amlapitta can be easily managed in early stage. In chronic conditions of Amlapitta, treatment should be given for very long time. And for this long-term treatment, there is need for herbal medicine to use.Pathyadi Churna and Avipattikar Churna are drugs having Amlapittahar property and Snigdha, Guru Gunas which is mentioned in Chakradutta and Bhaisajya Ratnavali as Amlapittahar yog. Churna Kalpna is a modified form of Kalka Kalpana and can be easily prescribed, Hence taking into consideration of its severity a combination of Haritaki , Bhringraj and Guda has taken to prove its efficacy for the satisfactory management of Amlapitta.Hence this topic is selected to study the efficacy of pathyadi churna and avipattikar churna in the management of amlapitta.the studywill be conducted for 21 days ,having follow up on 7th ,14th and 21st day.pathyadi churna and avipattikar churna will be given for 21 days before food with water.Before and After treatment assessment will be done with help of symptom relief.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Participants between Age group -18-60 years 2) Participants irrespective of age,sex,caste,religion 3) Participants presenting with primary classical features of the Amlapitta with 1 or more secondary features will be selected.

排除标准

  • Pregnant & lactating mothers.
  • Participants on NSAIDs. 3) Participants on long term steroids (for more than 6 months) 4) Known case of Intestinal TB, CA Stomach.
  • Known case of DM, Kidney diseases, Hepatobiliary diseases and Ulcerative colitis.

结局指标

主要结局

To determine the effect of pathyadi churna in the

时间窗: 21 days

management of amlapitta.

时间窗: 21 days

次要结局

  • 1)To study Safety of pathyadi churna & avipattikar churna in the management of amlapitta.(2)To understand in detail Samprapti of Amlapitta)

研究者

发起方
Dr Samarth Kasliwal
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Samarth Kasliwal

Seth Govindji Raoji Ayurved Mahavidhyalaya

研究点 (1)

Loading locations...

相似试验